Status:

ENROLLING_BY_INVITATION

Diagnostic Accuracy of Endocytoscopy for Superficial Esophageal Neoplasia

Lead Sponsor:

Changhai Hospital

Collaborating Sponsors:

Ruijin Hospital

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Conditions:

Esophageal Cancer, Squamous Cell

Eligibility:

All Genders

18-85 years

Brief Summary

In recent years, endocytoscopy (EC) has undergone rapid development as an advanced endoscopic technique. Characterized by real-time histological imaging and detection capabilities, EC enables visualiz...

Eligibility Criteria

Inclusion

  • Patients diagnosed with superficial esophageal squamous cell carcinoma or high-grade intraepithelial neoplasia (HGIN) through endoscopic and pathological biopsy examinations, scheduled for endoscopic submucosal dissection (ESD); 2.Patients with esophageal squamous low-grade intraepithelial neoplasia (LGIN) confirmed by endoscopic and biopsy histopathological examinations within the preceding six months; 3. Patients exhibiting esophageal focal lesions detected during painless upper gastrointestinal endoscopy requiring pathological biopsy.

Exclusion

  • Patients aged \<18 years or \>80 years;
  • Lesions located at the gastroesophageal junction with clinical suspicion of adenocarcinoma or precancerous lesions;
  • Patients with contraindications to sedated/anesthetized upper gastrointestinal endoscopy;
  • Patients with coagulation disorders;
  • Patients with a history of hypersensitivity to relevant medications (including anesthetics or methylene blue);
  • Patients presenting dysphagia or gastrointestinal obstructive symptoms, or those with suspected/confirmed digestive tract obstruction, stenosis, or fistulae;
  • Patients declining to provide informed consent for study participation, or any other circumstances deemed by investigators to preclude eligibility.

Key Trial Info

Start Date :

March 11 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

600 Patients enrolled

Trial Details

Trial ID

NCT06984055

Start Date

March 11 2025

End Date

December 1 2026

Last Update

May 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Changhai hosipital

Shanghai, Shanghai Municipality, China, 20000